Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1988 3
1989 1
1990 3
1992 4
1993 4
1994 3
1996 2
1997 7
1998 7
1999 5
2000 1
2001 8
2002 4
2003 11
2004 8
2005 6
2006 3
2007 6
2008 11
2009 6
2010 8
2011 7
2012 9
2013 4
2014 6
2015 8
2016 10
2017 9
2018 8
2019 12
2020 10
2021 8
2022 9
2023 8

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Pediatric ocular melanoma: a collaborative multicenter study and meta-analysis.
Masoomian B, Dalvin LA, Riazi-Esfahani H, Ghassemi F, Azizkhani M, Mirghorbani M, Khorrami-Nejad M, Sajjadi Z, Kaliki S, Sagoo MS, Al Harby L, Al-Jamal RT, Kivelä TT, Giblin M, Lim LS, Shields CL. Masoomian B, et al. J AAPOS. 2023 Nov 8:S1091-8531(23)00239-2. doi: 10.1016/j.jaapos.2023.08.021. Online ahead of print. J AAPOS. 2023. PMID: 37949393 Review.
PURPOSE: To investigate clinical manifestations and prognoses in pediatric patients (12 years old) with ocular melanoma. METHODS: This was a retrospective, multicenter cohort study with individual participant data (IPD) meta-analysis pooling available publish …
PURPOSE: To investigate clinical manifestations and prognoses in pediatric patients (12 years old) with ocular melanoma. METHO …
The collaborative ocular melanoma study.
Singh AD, Kivelä T. Singh AD, et al. Ophthalmol Clin North Am. 2005 Mar;18(1):129-42, ix. doi: 10.1016/j.ohc.2004.11.004. Ophthalmol Clin North Am. 2005. PMID: 15763198 Review.
This review provides a summary of the main objectives, significant design features, and major findings and achievements of the Collaborative Ocular Melanoma Study (COMS). It has been written by two ophthalmic oncologists who were not part of the COMS …
This review provides a summary of the main objectives, significant design features, and major findings and achievements of the Collaborat …
The Collaborative Ocular Melanoma Study: an overview.
Margo CE. Margo CE. Cancer Control. 2004 Sep-Oct;11(5):304-9. doi: 10.1177/107327480401100504. Cancer Control. 2004. PMID: 15377989 Free article. Review.
BACKGROUND: The Collaborative Ocular Melanoma Study (COMS) is a 3-arm study that includes two multicenter randomized clinical trials designed to compare the effectiveness of brachytherapy to enucleation for treatment of medium-size choroidal …
BACKGROUND: The Collaborative Ocular Melanoma Study (COMS) is a 3-arm study that includes two multicenter …
Collaborative ocular melanoma study randomized trial of I-125 brachytherapy.
Hawkins BS. Hawkins BS. Clin Trials. 2011 Oct;8(5):661-73. doi: 10.1177/1740774511419684. Clin Trials. 2011. PMID: 22013172 Clinical Trial.
PURPOSE: The Collaborative Ocular Melanoma Study (COMS) was designed to compare enucleation and radiotherapy among similar patients with respect to survival outcomes. ...CONCLUSIONS: The multidisciplinary COMS Group not only successfully conducted a ra …
PURPOSE: The Collaborative Ocular Melanoma Study (COMS) was designed to compare enucleation and radiotherapy amo …
Clinical outcomes of Modified Collaborative Ocular Melanoma Study IRIS plaques for treatment of iris, iridociliary, and ciliary body melanoma.
Xu TT, Pulido JS, Deufel CL, Corbin KS, Petersen IA, Dalvin LA. Xu TT, et al. Eye (Lond). 2021 Oct;35(10):2754-2762. doi: 10.1038/s41433-020-01295-y. Epub 2020 Nov 24. Eye (Lond). 2021. PMID: 33235338 Free PMC article.
BACKGROUND/OBJECTIVES: To report clinical outcomes of modified Collaborative Ocular Melanoma Study IRIS (COMS IRIS) plaques for treatment of iris, iridociliary, and ciliary body melanoma. SUBJECTS/METHODS: Retrospective, single-centre cohort …
BACKGROUND/OBJECTIVES: To report clinical outcomes of modified Collaborative Ocular Melanoma Study IRIS (COMS IR …
The collaborative Ocular Melanoma Study.
Davis MD, Fine SL, Kupfer C. Davis MD, et al. Arch Ophthalmol. 1994 Jun;112(6):730-1. doi: 10.1001/archopht.1994.01090180028009. Arch Ophthalmol. 1994. PMID: 8002824 No abstract available.
Optic Disc Dose Comparison Between 125I and 103Pd Collaborative Ocular Melanoma Study (COMS) Plaques Based on Current Clinical Practice.
Lee YC, Lin SC, Kim Y. Lee YC, et al. Cureus. 2021 Jun 28;13(6):e15980. doi: 10.7759/cureus.15980. eCollection 2021 Jun. Cureus. 2021. PMID: 34336471 Free PMC article.
Purpose The purpose of this study is to compare optic disc dose (ODD) between (125)I and (103)Pd Collaborative Ocular Melanoma Study (COMS) plaques in ocular brachytherapy. ...For small BDs, at DT <d(t), ODD for (103)Pd COMS plaques is …
Purpose The purpose of this study is to compare optic disc dose (ODD) between (125)I and (103)Pd Collaborative Ocular …
205 results